HomeInsightsStock Comparison

Gujarat Themis Biosyn Ltd vs Influx Healthtech Ltd Stock Comparison

Gujarat Themis Biosyn Ltd vs Influx Healthtech Ltd Stock Comparison

Last Updated on: Jul 05, 2025

Key Highlights

  • The Latest Trading Price of Gujarat Themis Biosyn Ltd is ₹ 350.45 as of 04 Jul 15:30.
  • The P/E Ratio of Gujarat Themis Biosyn Ltd changed from 6 on March 2020 to 0 on March 2025 . This represents a CAGR of -100.00% over 6 yearsThe P/E Ratio of Influx Healthtech Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 years.
  • The Market Cap of Gujarat Themis Biosyn Ltd changed from ₹ 141.22 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of Influx Healthtech Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 6 years.
  • The revenue of Gujarat Themis Biosyn Ltd for the Mar '25 is ₹ 39.08 crore as compare to the Dec '24 revenue of ₹ 39.76 crore. This represent the decline of -1.71% The revenue of Influx Healthtech Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Gujarat Themis Biosyn Ltd for the Mar '25 is ₹ 17.39 crore as compare to the Dec '24 ebitda of ₹ 19.11 crore. This represent the decline of -9% The ebitda of Influx Healthtech Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Gujarat Themis Biosyn Ltd changed from ₹ 17.72 crore to ₹ 12 crore over 8 quarters. This represents a CAGR of -17.71% The net profit of Influx Healthtech Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Gujarat Themis Biosyn Ltd changed from 10.12 % on March 2020 to 0 % on March 2025 . This represents a CAGR of -100.00% over 6 yearsThe Dividend Payout of Influx Healthtech Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Gujarat Themis Biosyn Ltd

  • Promoted byJayshree D Patel, Gujarat Themis Biosyn Limited was incorporated in 1981 as a joint sector company with Gujarat Industrial Investment Corporation Ltd (GIIC) and Chemosyn (P) Ltd. The Company commenced production in August 1985.
  • It was subsequently taken over in June 1991 by Yuhan Group, South Korea and Pharmaceutical Business Group (India) Ltd. (PBG); a unique consortium of five competing drug companies - Themis Medicare Ltd., Kopran Ltd., Anant & Co., Cadila Health Care Ltd. (Zydus) and Lyka Labs Ltd. It is being actively managed by Themis Medicare Ltd. (JV company of Gedeon Richter Ltd, Hungary) since 2007. Initially manufacturing the antibiotic, erythromycin, GTBL obtained licences to manufacture bulk drugs like rifampicin, cephalexin, griseofulvin and their formulations in 1990.

About Influx Healthtech Ltd

  • Influx Healthtech Limited was originally incorporated on September 28, 2020 as a Private Limited Company as 'Influx Healthtech Private Limited' with the Registrar of Companies, Central Registration Centre.
  • Company converted from a Private Limited to Public Limited and the name of Company was changed to Influx Healthtech Limited' and a Fresh Certificate of Incorporation upon the conversion was issued on May 23, 2022 by the Registrar of Companies, Mumbai. Influx Healthtech Limited is a a Mumbai-based healthcare product-focused company that has carved a niche in manufacturing Soft Gelatin, Tablets, Capsules, Liquid Orals, Oral Powders, Liquid fill capsules, Effervescent tablets, Nutra Pallets, Protein Bars, Cookies, Jellies/ Gummies, External preparations like Creams, Gels, Ointments, External Oils, Soaps, etc.

Gujarat Themis Biosyn Ltd News Hub

News

Board of Gujarat Themis Biosyn recommends final dividend

Gujarat Themis Biosyn announced that the Board of Directors of the Company at its meeting ...

Read more

21 May 2025 11:36

News

Gujarat Themis Biosyn to announce Quarterly Result

Gujarat Themis Biosyn will hold a meeting of the Board of Directors of the Company on 20 M...

Read more

16 May 2025 15:57

News

Gujarat Themis Biosyn to convene board meeting

Gujarat Themis Biosyn will hold a meeting of the Board of Directors of the Company on 14 F...

Read more

11 Feb 2025 10:53

News

Board approved merger of Gujarat Themis Biosyn with Themis Medicare

The Board of Directors of Gujarat Themis Biosyn (GTBL) and Themis Medicare (TML) have appr...

Read more

19 Nov 2024 09:10

News

Gujarat Themis Biosyn schedules board meeting

Gujarat Themis Biosyn will hold a meeting of the Board of Directors of the Company on 25 O...

Read more

19 Oct 2024 09:25

News

Gujarat Themis' Q1 PAT falls over 25% YoY to Rs 13 crore

This decline was primarily driven by a 21.7% YoY drop in net sales to Rs 38.83 crore. Tota...

Read more

27 Jul 2024 09:25

Influx Healthtech Ltd News Hub

News

NSE SME Influx Healthtech makes a strong debut

The scrip was listed at Rs 132.50, a premium of 38.02% compared with the initial public of...

Read more

25 Jun 2025 11:42

SWOT Analysis Of Gujarat Themis Biosyn Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Gujarat Themis Biosyn Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Gujarat Themis Biosyn Ltd and Influx Healthtech Ltd

Which company has a larger market capitalization, Gujarat Themis Biosyn Ltd or Influx Healthtech Ltd?

Market cap of Gujarat Themis Biosyn Ltd is 3,818 Cr while Market cap of Influx Healthtech Ltd is 304 Cr

What are the key factors driving the stock performance of Gujarat Themis Biosyn Ltd and Influx Healthtech Ltd?

The stock performance of Gujarat Themis Biosyn Ltd and Influx Healthtech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Gujarat Themis Biosyn Ltd and Influx Healthtech Ltd?

As of July 5, 2025, the Gujarat Themis Biosyn Ltd stock price is INR ₹350.45. On the other hand, Influx Healthtech Ltd stock price is INR ₹131.35.

How do dividend payouts of Gujarat Themis Biosyn Ltd and Influx Healthtech Ltd compare?

To compare the dividend payouts of Gujarat Themis Biosyn Ltd and Influx Healthtech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions